Home

EVA

European Virus Archive - AISBL
  • Contact Us
  • FAQs
  • Login / Register
  • Linkedin
  • X
  • Facebook
  • Youtube
  • Home
  • Portal
  • The association
    • Who we are
    • Concept & Approach
    • Our history
    • Members
    • ABS Strategy
    • DURC issues
  • News
    • News
    • Publications
    • Newsletters
  • Industrials
  • Home
  • News
  • News

News

Latest news

  • September 30, 2020

    SARS-CoV-2: antiviral compounds test results

    EVAg
  • June 5, 2020

    Access and benefit sharing under the Convention on Biological Diversity and the Nagoya Protocol

    EVAg
  • April 9, 2020

    In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

    EVAg
  • February 17, 2020

    Biobanking E-learning Training

    EVAg
  • January 15, 2020

    SARS-CoV-2 collection

    EVAg
  • November 30, 2016

    NGS Workshop

    NGS
  • October 26, 2016

    ASTMH 2016 - Atlanta

    ASTMH
  • February 4, 2016

    ZIKA Virus diagnostics

    Aedes aegypti mosquito and Zika virus
  • January 11, 2016

    Viruses conference 2016 Basel

    EVAg
  • January 8, 2016

    ZIKA Virus

    EVAg
  • ‹ previous
  • 4 of 5
  • next ›
Hotline

Urgent Collection Matters

If you are facing a time-critical situation involving virus collections—such as retirement, laboratory closure, risk of loss of materials, or the availability of samples linked to an outbreak—EVA AISBL may assist in identifying appropriate solutions within its network.



Contact us

EVAg

The European Virus Archive - AISBL is an international non-profit association


  • FAQs
  • Sitemap
  • Legal mentions
  • Newsletter
  • Contact
  • Linkedin
  • X
  • Facebook
  • Youtube
The EVA community supports fair and equitable benefit sharing as conceived in various United Nations frameworks. The consortium is actively implementing a CBD/Nagoya Protocol compliance strategy. Learn more ...